Merck Total Liabilities and Share Holders Equity 2010-2024 | MKKGY
Merck total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Merck total liabilities and share holders equity for the quarter ending June 30, 2024 was $53.710B, a 0.97% increase year-over-year.
- Merck total liabilities and share holders equity for 2023 was $52.486B, a 2.66% increase from 2022.
- Merck total liabilities and share holders equity for 2022 was $51.127B, a 4.73% decline from 2021.
- Merck total liabilities and share holders equity for 2021 was $53.668B, a 12.41% increase from 2020.
Merck Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$52,486 |
| 2022 |
$51,127 |
| 2021 |
$53,668 |
| 2020 |
$47,744 |
| 2019 |
$49,068 |
| 2018 |
$43,565 |
| 2017 |
$40,262 |
| 2016 |
$42,329 |
| 2015 |
$42,177 |
| 2014 |
$34,575 |
| 2013 |
$27,653 |
| 2012 |
$27,835 |
| 2011 |
$30,813 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-06-30 |
$53,710 |
| 2024-03-31 |
$53,746 |
| 2023-12-31 |
$52,486 |
| 2023-09-30 |
$54,318 |
| 2023-06-30 |
$53,192 |
| 2023-03-31 |
$52,207 |
| 2022-12-31 |
$51,127 |
| 2022-09-30 |
$51,300 |
| 2022-06-30 |
$51,845 |
| 2022-03-31 |
$51,885 |
| 2021-12-31 |
$53,668 |
| 2021-09-30 |
$51,691 |
| 2021-06-30 |
$51,985 |
| 2021-03-31 |
$52,915 |
| 2020-12-31 |
$47,744 |
| 2020-09-30 |
$50,537 |
| 2020-06-30 |
$48,252 |
| 2020-03-31 |
$49,360 |
| 2019-12-31 |
$49,068 |
| 2019-09-30 |
$46,779 |
| 2019-06-30 |
$44,474 |
| 2019-03-31 |
$43,975 |
| 2018-12-31 |
$43,565 |
| 2018-09-30 |
$41,555 |
| 2018-06-30 |
$42,728 |
| 2018-03-31 |
$43,237 |
| 2017-12-31 |
$40,262 |
| 2017-09-30 |
$42,111 |
| 2017-06-30 |
$40,448 |
| 2017-03-31 |
$40,871 |
| 2016-12-31 |
$42,329 |
| 2016-09-30 |
$41,004 |
| 2016-06-30 |
$41,825 |
| 2016-03-31 |
$41,010 |
| 2015-12-31 |
$42,177 |
| 2015-09-30 |
$35,900 |
| 2015-06-30 |
$32,969 |
| 2015-03-31 |
$34,721 |
| 2014-12-31 |
$34,575 |
| 2014-09-30 |
$30,149 |
| 2014-06-30 |
$29,461 |
| 2014-03-31 |
$28,792 |
| 2013-12-31 |
$27,653 |
| 2013-09-30 |
$28,251 |
| 2013-06-30 |
$28,456 |
| 2013-03-31 |
$28,999 |
| 2012-12-31 |
$27,835 |
| 2012-09-30 |
$27,864 |
| 2012-06-30 |
$28,137 |
| 2012-03-31 |
|
| 2011-12-31 |
$30,813 |
| 2011-09-30 |
|
| 2011-06-30 |
$31,500 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$29,683 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
